Cargando…

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration

Time to onset of response and duration of response are key measures of botulinum toxin efficacy that have a considerable influence on patient satisfaction with aesthetic treatment. However, there is no overall accepted definition of efficacy for aesthetic uses of botulinumtoxinA (BoNT-A). Mechanical...

Descripción completa

Detalles Bibliográficos
Autores principales: Nestor, Mark, Ablon, Glynis, Pickett, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434495/
https://www.ncbi.nlm.nih.gov/pubmed/28388717
http://dx.doi.org/10.1093/asj/sjw282
_version_ 1783237059723395072
author Nestor, Mark
Ablon, Glynis
Pickett, Andy
author_facet Nestor, Mark
Ablon, Glynis
Pickett, Andy
author_sort Nestor, Mark
collection PubMed
description Time to onset of response and duration of response are key measures of botulinum toxin efficacy that have a considerable influence on patient satisfaction with aesthetic treatment. However, there is no overall accepted definition of efficacy for aesthetic uses of botulinumtoxinA (BoNT-A). Mechanical methods of assessment do not lend themselves to clinical practice and clinicians rely instead on assessment scales such as the Frontalis Activity Measurement Standard, Frontalis Rating Scale, Wrinkle Severity Scale, and Subject Global Assessment Scale, but not all of these have been fully validated. Onset of activity is typically seen within 5 days of injection, but has also been recorded within 12 hours with abobotulinumtoxinA. Duration of effect is more variable, and is influenced by parameters such as muscle mass (including the effects of age and sex) and type of product used. Even when larger muscles are treated with higher doses of BoNT-A, the duration of effect is still shorter than that for smaller muscles. Muscle injection technique, including dilution of the toxin, the volume of solution injected, and the positioning of the injections, can also have an important influence on onset and duration of activity. Comparison of the efficacy of different forms of BoNT-A must be made with the full understanding that the dosing units are not equivalent. Range of equivalence studies for abobotulinumtoxinA (Azzalure; Ipsen Limited, Slough UK/Galderma, Lausanne CH/Dysport, Ipsen Biopharm Limited, Wrexham UK/Galderma LP, Fort Worth, TX) and onabotulinumtoxinA (Botox; Allergan, Parsippany, NJ) have been conducted, and results indicate that the number of units of abobotulinumtoxinA needs to be approximately twice as high as that of onabotulinumtoxinA to achieve the same effect. An appreciation of the potential influence of all of the parameters that influence onset and duration of activity of BoNT-A, along with a thorough understanding of the anatomy of the face and potency of doses, are essential to tailoring treatment to individual patient needs and expectations.
format Online
Article
Text
id pubmed-5434495
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54344952017-05-22 Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration Nestor, Mark Ablon, Glynis Pickett, Andy Aesthet Surg J Supplement Articles Time to onset of response and duration of response are key measures of botulinum toxin efficacy that have a considerable influence on patient satisfaction with aesthetic treatment. However, there is no overall accepted definition of efficacy for aesthetic uses of botulinumtoxinA (BoNT-A). Mechanical methods of assessment do not lend themselves to clinical practice and clinicians rely instead on assessment scales such as the Frontalis Activity Measurement Standard, Frontalis Rating Scale, Wrinkle Severity Scale, and Subject Global Assessment Scale, but not all of these have been fully validated. Onset of activity is typically seen within 5 days of injection, but has also been recorded within 12 hours with abobotulinumtoxinA. Duration of effect is more variable, and is influenced by parameters such as muscle mass (including the effects of age and sex) and type of product used. Even when larger muscles are treated with higher doses of BoNT-A, the duration of effect is still shorter than that for smaller muscles. Muscle injection technique, including dilution of the toxin, the volume of solution injected, and the positioning of the injections, can also have an important influence on onset and duration of activity. Comparison of the efficacy of different forms of BoNT-A must be made with the full understanding that the dosing units are not equivalent. Range of equivalence studies for abobotulinumtoxinA (Azzalure; Ipsen Limited, Slough UK/Galderma, Lausanne CH/Dysport, Ipsen Biopharm Limited, Wrexham UK/Galderma LP, Fort Worth, TX) and onabotulinumtoxinA (Botox; Allergan, Parsippany, NJ) have been conducted, and results indicate that the number of units of abobotulinumtoxinA needs to be approximately twice as high as that of onabotulinumtoxinA to achieve the same effect. An appreciation of the potential influence of all of the parameters that influence onset and duration of activity of BoNT-A, along with a thorough understanding of the anatomy of the face and potency of doses, are essential to tailoring treatment to individual patient needs and expectations. Oxford University Press 2017-05 2017-04-07 /pmc/articles/PMC5434495/ /pubmed/28388717 http://dx.doi.org/10.1093/asj/sjw282 Text en © 2017 The American Society for Aesthetic Plastic Surgery, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Articles
Nestor, Mark
Ablon, Glynis
Pickett, Andy
Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title_full Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title_fullStr Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title_full_unstemmed Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title_short Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
title_sort key parameters for the use of abobotulinumtoxina in aesthetics: onset and duration
topic Supplement Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434495/
https://www.ncbi.nlm.nih.gov/pubmed/28388717
http://dx.doi.org/10.1093/asj/sjw282
work_keys_str_mv AT nestormark keyparametersfortheuseofabobotulinumtoxinainaestheticsonsetandduration
AT ablonglynis keyparametersfortheuseofabobotulinumtoxinainaestheticsonsetandduration
AT pickettandy keyparametersfortheuseofabobotulinumtoxinainaestheticsonsetandduration